FDA
FDA Updates
The U.S. Food and Drug Administration today approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection for weight loss and long-term maintenance of weight loss for certain adult patients.
FDA
FDA Updates
The U.S. Food and Drug Administration today announced the issuance of 30 warning letters to telehealth companies for making false or misleading claims regarding compounded GLP-1 products offered on their websites.
Sources & methodology. Items aggregated from public scientific and regulatory sources: PubMed (NCBI E-utilities), FDA press releases, and ClinicalTrials.gov v2 API. Summaries are factual excerpts from source records — no editorial commentary. Inclusion does not imply endorsement, and items are not medical advice. Last regenerated: 2026-04-26.